PT87704A - Process for preparing pharmaceutical compositions for transdermal delivery containing a 1,4-dihydropyride derivative - Google Patents

Process for preparing pharmaceutical compositions for transdermal delivery containing a 1,4-dihydropyride derivative

Info

Publication number
PT87704A
PT87704A PT87704A PT8770488A PT87704A PT 87704 A PT87704 A PT 87704A PT 87704 A PT87704 A PT 87704A PT 8770488 A PT8770488 A PT 8770488A PT 87704 A PT87704 A PT 87704A
Authority
PT
Portugal
Prior art keywords
transdermal delivery
dihydropyride
derivative
pharmaceutical compositions
preparing pharmaceutical
Prior art date
Application number
PT87704A
Other languages
English (en)
Other versions
PT87704B (pt
Inventor
John Michael Pawelchak
James Ronald Lawter
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PT87704A publication Critical patent/PT87704A/pt
Publication of PT87704B publication Critical patent/PT87704B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
PT87704A 1987-06-12 1988-06-09 Processo para a preparacao de composicoes farmaceuticas para administracao transdermica contendo um derivado de 1,4-di-hidropiridina PT87704B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6184287A 1987-06-12 1987-06-12

Publications (2)

Publication Number Publication Date
PT87704A true PT87704A (pt) 1988-07-01
PT87704B PT87704B (pt) 1993-03-31

Family

ID=22038497

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87704A PT87704B (pt) 1987-06-12 1988-06-09 Processo para a preparacao de composicoes farmaceuticas para administracao transdermica contendo um derivado de 1,4-di-hidropiridina

Country Status (16)

Country Link
EP (1) EP0294601B1 (pt)
JP (1) JP2654092B2 (pt)
KR (1) KR970000506B1 (pt)
AT (1) ATE84714T1 (pt)
AU (1) AU609142B2 (pt)
CA (1) CA1305418C (pt)
DE (1) DE3877630T2 (pt)
DK (1) DK171746B1 (pt)
ES (1) ES2043719T3 (pt)
GR (1) GR3006938T3 (pt)
IE (1) IE62735B1 (pt)
IL (1) IL86334A (pt)
NO (1) NO178096C (pt)
NZ (1) NZ224891A (pt)
PT (1) PT87704B (pt)
ZA (1) ZA884186B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US5476854A (en) * 1991-11-27 1995-12-19 Sepracor Inc. Methods and compositions for treating bacterial infection using optically pure (R)-lomefloxacin
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
DE69333009T2 (de) * 1992-11-09 2003-12-04 Neurogesx Inc Transdermale verabreichung von ketorolac
CN100391462C (zh) 2001-06-18 2008-06-04 诺芬药品公司 增强的透皮给药系统
CN100444840C (zh) 2003-05-15 2008-12-24 罗斯坎普研究有限公司 减少淀粉样沉积、淀粉样神经毒性和小胶质增生的药物
CA2701620C (en) 2007-10-05 2014-12-09 Alzheimer's Institute Of America, Inc. Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
JPS6016917A (ja) * 1983-07-08 1985-01-28 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンまたはニフエジピンの軟膏剤
JPS60258179A (ja) * 1984-06-04 1985-12-20 Yamanouchi Pharmaceut Co Ltd Ｙｍ−０９７３０のジアステレオマ−ａの右旋性光学異性体またはその酸付加塩，該化合物の製造方法および該化合物からなる医薬
DE3419128A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinpraeparate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
KR970000506B1 (ko) 1997-01-13
DK171746B1 (da) 1997-05-05
KR890000090A (ko) 1989-03-11
IE881749L (en) 1988-12-12
ES2043719T3 (es) 1994-01-01
AU609142B2 (en) 1991-04-26
EP0294601A3 (en) 1989-10-11
CA1305418C (en) 1992-07-21
DE3877630D1 (de) 1993-03-04
GR3006938T3 (pt) 1993-06-30
IE62735B1 (en) 1995-02-22
AU1761088A (en) 1988-12-15
NO882559L (no) 1988-12-13
NO178096C (no) 1996-01-24
ZA884186B (en) 1989-03-29
NO882559D0 (no) 1988-06-10
EP0294601B1 (en) 1993-01-20
DE3877630T2 (de) 1993-06-03
ATE84714T1 (de) 1993-02-15
EP0294601A2 (en) 1988-12-14
NZ224891A (en) 1992-06-25
PT87704B (pt) 1993-03-31
DK316788A (da) 1988-12-13
DK316788D0 (da) 1988-06-10
IL86334A (en) 1992-09-06
NO178096B (no) 1995-10-16
JP2654092B2 (ja) 1997-09-17
JPS6413024A (en) 1989-01-17

Similar Documents

Publication Publication Date Title
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
FR2680507B1 (fr) Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
UA32543C2 (uk) Арилацетаміди, що мають анальгетичну дію, спосіб їх одержання, фармацевтична композиція та спосіб її одержання
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
FI901096A0 (fi) Menetelmä farmakologisesti aktiivisten /3-(C16-C18)alkaanisulfinyyli- ja -sulfonyyli-2-metoksimetyylipropyyli/-(2-trimetyyliammonio-etyyli)fosfaattien valmistamiseksi
FI901328A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisen (7 ,17 )-17-hydroksi-7-metyyli-19-nor-17-pregn-5(10)-en-20-yn-3-onin valmistamiseksi kiteisenä puhtaana muotona
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
DE59300176D1 (de) 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
PT87704A (pt) Process for preparing pharmaceutical compositions for transdermal delivery containing a 1,4-dihydropyride derivative
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
IL61989A (en) 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them
IL77051A (en) Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it
CS318690A3 (en) Pharmaceutical composition usable for depression therapy
HUT47020A (en) Process for production of stabilly injectable medical compounds containing as active substance 1,4-dihidroxi-5,8-bis/2/2-hidroxi-ethil-amin/-ethil-amin-antraquinon-dihydrochlorid
ATE140228T1 (de) Hydroxymethyl-indolizidine und -chinolizidine
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
DE3466877D1 (en) Crystalline salts of l or (s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
PT95757A (pt) Processo de preparacao de composicoes farmaceuticas a basede n-metil-2-(piridil-3)-tetra-hidrotiopirano-carbotioamida-2-oxido-1

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920928

PD3A Change of proprietorship

Free format text: WYETH HOLDINGS CORPORATION US

Effective date: 20031117

TE3A Change of address (patent)

Free format text: AMERICAN CYANAMID COMPANY US

Effective date: 20031117

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080609